Open AccessRight Ventricle and Cardiac Resynchronization Therapy. Spectator or Actor?
Author(s) -
Silvia Deaconu,
Alexandru Deaconu,
Aura Vîjîiac,
Alexandra Acostachioaiei,
Maria Dorobanțu
Publication year - 2021
Publication title -
romanian journal of cardiology
Language(s) - English
Resource type - Journals
eISSN - 2734-6382
pISSN - 1220-658X
DOI - 10.47803/rjc.2021.31.2.303
Subject(s) - ejection fraction , cardiac resynchronization therapy , ventricle , medicine , cardiology , heart failure , ventricular dyssynchrony , adverse effect
Lately, RV dysfunction has emerged as a signifi cant prognostic factor in heart failure with reduced ejection fraction (HFrEF). More so, recent data show a specific pattern of RV contraction in LBBB patients that is corrected by CRT, but not in patients with RV failure. The importance of RV evaluation in CRT patients is still under debate. Establishing the role of RV function in the setting of CRT may help identify patients with high risk of adverse events. Moreover, the changes induced by CRT upon RV may lead to a better understanding of the mechanisms behind CRT effects and may facilitate novel criteria for optimal selection of CRT candidates.